URGN UroGen Pharma Ltd.

$42.31▲ +0.17% Healthcare Other
After hours $43.00▲ +1.63% Sep 11, 7:30 PM ET
Volume 676.5K Avg Volume (10D) 703.9K
Key Metrics & Fundamentals
Market Cap
$2.07B
P/E Ratio
–
Div Yield
–%
52W Range
15.86 - 50.81
% vs 50 MA
-2.08%
% vs 200 MA
47.73%
RSI-14
42.6
MACD Histogram
-0.5900
Beta (1Y vs SPY)
1.23
Free Cash Flow
-$33.07M
Gross Rev
$72.46M
Gross Profit
$65.88M
EBITDA
-$3.17M
COGS
$6.57M
Operating Exp
$65.77M
Operating Income
$111,000
EBIT
$111,000
Pretax Income
-$8.72M
Net Income
-$14.35M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress
Barrons.com · Sep 9, 2026 2:44 PM
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 12:00 PM
UroGen Pharma to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 12:00 PM
Urogen Pharma Insider Sold Shares Worth $2,854,853, According to a Recent SEC Filing
MT Newswires · Aug 24, 2026 9:07 PM
Wall Street Analysts Think Urogen Pharma (URGN) Could Surge 27.14%: Read This Before Placing a Bet
Zacks · Aug 21, 2026 1:55 PM
UroGen Signs Investment, Collaboration Agreements With IntraGel for Access to Sustained-Release Platform
MT Newswires · Aug 20, 2026 11:45 AM
IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies
PR Newswire · Aug 20, 2026 11:05 AM
UroGen Announces Strategic Collaboration and Investment Agreements with IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline
GlobeNewswire · Aug 20, 2026 11:00 AM
Sector Update: Healthcare Stocks Mixed Monday Afternoon
MT Newswires · Aug 17, 2026 5:38 PM
Sector Update: Healthcare
MT Newswires · Aug 17, 2026 5:15 PM
Financial Overview - Income Statement Quarterly

See URGN's money flow as a full page

Social Sentiment
Avg +0.55 · 4 posts
NewsDiscussionPriceTargetURGN cane down to $12 from $14 after FDA approval, future potential?
r/options · Jun 13, 2025
The post expresses a question about future potential after FDA approval, suggesting optimism towards the stock.
positive +0.30
DDNewsPriceTargetURGN Received FDA approval target price 30+ current price 12.60.
r/options · Jun 13, 2025
The post highlights positive developments (FDA approval, analyst upside) regarding URGN, indicating optimism.
positive +0.70
NewsDiscussionEarningsTradePriceTargetUroGen Pharma Ltd. (URGN)
r/StockMarket · Jun 19, 2024
The post details positive trial data, revenue growth expectations, and a stock price jump, indicating a bullish sentiment.
positive +0.60
DiscussionPriceTargetthoughts on $urgn's 40% surge today
r/wallstreetbets · Jun 13, 2024
The user is directly asking about the stock's movement, indicating potential bullish sentiment.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙